Atlas Trials

Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects

Clinical trial NCT06247748 · COMPLETED

Trial details

NCT number
NCT06247748
Sponsor
Beijing Dongfang Biotech Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Overweight
Start date
2023-10-19
Primary completion
2024-04-15
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.